T-bet deficiency attenuates cardiac remodelling in rats

Basic Research in Cardiology

Volumn 113, Issue 3, 2018, Pages

  Ma, Zhen Guo ^a,b,c   Dai, Jia ^a,b,c   Yuan, Yu Pei ^a,b,c   Bian, Zhou Yan ^a,b,c   Xu, Si Chi ^a,b,c   Jin, Ya Ge ^a,b,c   Zhang, Xin ^a,b,c   Tang, Qi Zhu ^a,b,c  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

^c HUBEI KEY LABORATORY OF CARDIOLOGY   (China)

Author keywords

Cardiac remodelling; Interferon ; T helper subset; T lymphocytes; T bet

Indexed keywords

GAMMA INTERFERON; NEUTRALIZING ANTIBODY; TRANSCRIPTION FACTOR T BET; CYTOKINE; T BOX TRANSCRIPTION FACTOR; T-BOX TRANSCRIPTION FACTOR TBX21;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC MUSCLE CELL; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; HEART VENTRICLE REMODELING; HUMAN; HUMAN TISSUE; LYMPHOCYTE HOMING; NEWBORN; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; ADOPTIVE TRANSFER; ANIMAL; CARDIOMEGALY; CELL CULTURE; CONGESTIVE CARDIOMYOPATHY; DEFICIENCY; DRUG EFFECT; GENE KNOCKDOWN; GENETICS; GENOTYPE; IMMUNOLOGY; METABOLISM; NEUTROPHIL CHEMOTAXIS; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PHENOTYPE; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; TH1 CELL; TRANSGENIC RAT; TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; CARDIOMEGALY; CARDIOMYOPATHY, DILATED; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; GENE KNOCKDOWN TECHNIQUES; GENOTYPE; HUMANS; INTERFERON-GAMMA; MYOCYTES, CARDIAC; PARACRINE COMMUNICATION; PHENOTYPE; RATS, SPRAGUE-DAWLEY; RATS, TRANSGENIC; SIGNAL TRANSDUCTION; T-BOX DOMAIN PROTEINS; TH1 CELLS; VENTRICULAR REMODELING;

EID: 85044339253     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-018-0678-x     Document Type: Article

References (41)

1. Aukrust P, Ueland T, Muller F, Andreassen AK, Nordoy I, Aas H, Kjekshus J, Simonsen S, Froland SS, Gullestad L (1998) Elevated circulating levels of c-c chemokines in patients with congestive heart failure. Circulation 97:1136–1143
2. Borthwick LA, Barron L, Hart KM, Vannella KM, Thompson RW, Oland S, Cheever A, Sciurba J, Ramalingam TR, Fisher AJ, Wynn TA (2016) Macrophages are critical to the maintenance of il-13-dependent lung inflammation and fibrosis. Mucosal Immunol 9:38–55. https://doi.org/10.1038/mi.2015.34
3. Bui AL, Horwich TB, Fonarow GC (2011) Epidemiology and risk profile of heart failure. Nat Rev Cardiol 8:30–41. https://doi.org/10.1038/nrcardio.2010.165
4. Chiaramonte MG, Donaldson DD, Cheever AW, Wynn TA (1999) An il-13 inhibitor blocks the development of hepatic fibrosis during a t-helper type 2-dominated inflammatory response. J Clin Invest 104:777–785. https://doi.org/10.1172/JCI7325
5. Fang J, Hu F, Ke D, Yan Y, Liao Z, Yuan X, Wu L, Jiang Q, Chen L (2016) N, N-dimethylsphingosine attenuates myocardial ischemia-reperfusion injury by recruiting regulatory T cells through PI3K/Akt pathway in mice. Basic Res Cardiol 111:32. https://doi.org/10.1007/s00395-016-0548-3
6. Finotto S, Neurath MF, Glickman JN, Qin S, Lehr HA, Green FH, Ackerman K, Haley K, Galle PR, Szabo SJ, Drazen JM, De Sanctis GT, Glimcher LH (2002) Development of spontaneous airway changes consistent with human asthma in mice lacking t-bet. Science 295:336–338. https://doi.org/10.1126/science.1065544
7. Frieler RA, Mortensen RM (2015) Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling. Circulation 131:1019–1030. https://doi.org/10.1161/CIRCULATIONAHA.114.008788
8. Garcia AG, Wilson RM, Heo J, Murthy NR, Baid S, Ouchi N, Sam F (2012) Interferon-gamma ablation exacerbates myocardial hypertrophy in diastolic heart failure. Am J Physiol Heart Circ Physiol 303:H587–H596. https://doi.org/10.1152/ajpheart.00298.2012
9. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C, Harrison DG (2007) Role of the t cell in the genesis of angiotensin ii induced hypertension and vascular dysfunction. J Exp Med 204:2449–2460. https://doi.org/10.1084/jem.20070657
10. Heusch G, Libby P, Gersh B, Yellon D, Böhm M, Lopaschuk G, Opie L (2014) Cardiovascular remodelling in coronary artery disease and heart failure. Lancet 383:1933–1943. https://doi.org/10.1016/S0140-6736(14)60107-0
11. Jenner RG, Townsend MJ, Jackson I, Sun K, Bouwman RD, Young RA, Glimcher LH, Lord GM (2009) The transcription factors t-bet and gata-3 control alternative pathways of t-cell differentiation through a shared set of target genes. Proc Natl Acad Sci USA 106:17876–17881. https://doi.org/10.1073/pnas.0909357106
12. Ji YX, Zhang P, Zhang XJ, Zhao YC, Deng KQ, Jiang X, Wang PX, Huang Z, Li H (2016) The ubiquitin e3 ligase traf6 exacerbates pathological cardiac hypertrophy via tak1-dependent signalling. Nat Commun 7:11267. https://doi.org/10.1038/ncomms11267
13. Jung M, Ma Y, Iyer RP, DeLeon-Pennell KY, Yabluchanskiy A, Garrett MR, Lindsey ML (2017) IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation. Basic Res Cardiol 112(3):33. https://doi.org/10.1007/s00395-017-0622-5
14. Kamo T, Akazawa H, Komuro I (2015) Cardiac nonmyocytes in the hub of cardiac hypertrophy. Circ Res 117:89–98. https://doi.org/10.1161/CIRCRESAHA.117.305349
15. Komuro I, Kurabayashi M, Takaku F, Yazaki Y (1988) Expression of cellular oncogenes in the myocardium during the developmental stage and pressure-overloaded hypertrophy of the rat heart. Circ Res 62:1075–1079
16. Laroumanie F, Douin-Echinard V, Pozzo J, Lairez O, Tortosa F, Vinel C, Delage C, Calise D, Dutaur M, Parini A, Pizzinat N (2014) Cd4 + t cells promote the transition from hypertrophy to heart failure during chronic pressure overload. Circulation 129:2111–2124. https://doi.org/10.1161/CIRCULATIONAHA.113.007101
17. Lazarevic V, Glimcher LH (2011) T-bet in disease. Nat Immunol 12:597–606. https://doi.org/10.1038/ni.2059
18. Lazarevic V, Glimcher LH, Lord GM (2013) T-bet: a bridge between innate and adaptive immunity. Nat Rev Immunol 13:777–789. https://doi.org/10.1038/nri3536
19. Ma ZG, Dai J, Wei WY, Zhang WB, Xu SC, Liao HH, Yang Z, Tang QZ (2016) Asiatic acid protects against cardiac hypertrophy through activating ampkalpha signalling pathway. Int J Biol Sci 12:861–871. https://doi.org/10.7150/ijbs.14213
20. Ma ZG, Dai J, Zhang WB, Yuan Y, Liao HH, Zhang N, Bian ZY, Tang QZ (2016) Protection against cardiac hypertrophy by geniposide involves the glp-1 receptor/ampkalpha signalling pathway. Br J Pharmacol 173:1502–1516. https://doi.org/10.1111/bph.13449
21. Ma ZG, Yuan YP, Xu SC, Wei WY, Xu CR, Zhang X, Wu QQ, Liao HH, Ni J, Tang QZ (2017) Ctrp3 attenuates cardiac dysfunction, inflammation, oxidative stress and cell death in diabetic cardiomyopathy in rats. Diabetologia 60:1126–1137. https://doi.org/10.1007/s00125-017-4232-4
22. Ma ZG, Yuan YP, Zhang X, Xu SC, Wang SS, Tang QZ (2017) Piperine attenuates pathological cardiac fibrosis via ppar-gamma/akt pathways. EBioMedicine 18:179–187. https://doi.org/10.1016/j.ebiom.2017.03.021
23. Marko L, Kvakan H, Park JK, Qadri F, Spallek B, Binger KJ, Bowman EP, Kleinewietfeld M, Fokuhl V, Dechend R, Muller DN (2012) Interferon-gamma signaling inhibition ameliorates angiotensin ii-induced cardiac damage. Hypertension 60:1430–1436. https://doi.org/10.1161/HYPERTENSIONAHA.112.199265
24. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jimenez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB (2016) Heart disease and stroke statistics-2016 update: a report from the american heart association. Circulation 133:e38–e360. https://doi.org/10.1161/CIR.0000000000000350
25. Nevers T, Salvador AM, Grodecki-Pena A, Knapp A, Velazquez F, Aronovitz M, Kapur NK, Karas RH, Blanton RM, Alcaide P (2015) Left ventricular t-cell recruitment contributes to the pathogenesis of heart failure. Circ Heart Fail 8:776–787. https://doi.org/10.1161/CIRCHEARTFAILURE.115.002225
26. Ramos G, Hofmann U, Frantz S (2016) Myocardial fibrosis seen through the lenses of t-cell biology. J Mol Cell Cardiol 92:41–45. https://doi.org/10.1016/j.yjmcc.2016.01.018
27. Rangachari M, Mauermann N, Marty RR, Dirnhofer S, Kurrer MO, Komnenovic V, Penninger JM, Eriksson U (2006) T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. J Exp Med 203:2009–2019. https://doi.org/10.1084/jem.20052222
28. Reifenberg K, Lehr HA, Torzewski M, Steige G, Wiese E, Kupper I, Becker C, Ott S, Nusser P, Yamamura K, Rechtsteiner G, Warger T, Pautz A, Kleinert H, Schmidt A, Pieske B, Wenzel P, Munzel T, Lohler J (2007) Interferon-gamma induces chronic active myocarditis and cardiomyopathy in transgenic mice. Am J Pathol 171:463–472. https://doi.org/10.2353/ajpath.2007.060906
29. Sadoshima J, Izumo S (1993) Molecular characterization of angiotensin ii–induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the at1 receptor subtype. Circ Res 73:413–423
30. Shao J, Nangaku M, Miyata T, Inagi R, Yamada K, Kurokawa K, Fujita T (2003) Imbalance of t-cell subsets in angiotensin ii-infused hypertensive rats with kidney injury. Hypertension 42:31–38. https://doi.org/10.1161/01.HYP.0000075082.06183.4E
31. Shimoyama M, Hayashi D, Takimoto E, Zou Y, Oka T, Uozumi H, Kudoh S, Shibasaki F, Yazaki Y, Nagai R, Komuro I (1999) Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy. Circulation 100:2449–2454
32. Simpson P, McGrath A, Savion S (1982) Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by catecholamines. Circ Res 51:787–801
33. Stolarczyk E, Vong CT, Perucha E, Jackson I, Cawthorne MA, Wargent ET, Powell N, Canavan JB, Lord GM, Howard JK (2013) Improved insulin sensitivity despite increased visceral adiposity in mice deficient for the immune cell transcription factor t-bet. Cell Metab 17:520–533. https://doi.org/10.1016/j.cmet.2013.02.019
34. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH (2000) A novel transcription factor, t-bet, directs th1 lineage commitment. Cell 100:655–669
35. Szabo SJ, Sullivan BM, Stemmann C, Satoskar AR, Sleckman BP, Glimcher LH (2002) Distinct effects of t-bet in th1 lineage commitment and ifn-gamma production in cd4 and cd8 t cells. Science 295:338–342. https://doi.org/10.1126/science.1065543
36. Tian X, Guo R, Zhang Y, Xu L, Liu X, Hou Y (2016) Effects of the sympathetic nervous system on regulatory t cell and t helper 1 chemokine expression in patients with acute coronary syndrome. Neuroimmunomodulat. https://doi.org/10.1159/000448660
37. Wang H, Kwak D, Fassett J, Liu X, Yao W, Weng X, Xu X, Xu Y, Bache RJ, Mueller DL, Chen Y (2017) Role of bone marrow-derived CD11c + dendritic cells in systolic overload-induced left ventricular inflammation, fibrosis and hypertrophy. Basic Res Cardiol 112:25. https://doi.org/10.1007/s00395-017-0615-4
38. Wei WY, Ma ZG, Xu SC, Zhang N, Tang QZ (2016) Pioglitazone protected against cardiac hypertrophy via inhibiting akt/gsk3beta and mapk signaling pathways. Ppar Res 2016:9174190. https://doi.org/10.1155/2016/9174190
39. Wu QQ, Yuan Y, Jiang XH, Xiao Y, Yang Z, Ma ZG, Liao HH, Liu Y, Chang W, Bian ZY, Tang QZ (2016) Ox40 regulates pressure overload-induced cardiac hypertrophy and remodelling via cd4 + t-cells. Clin Sci (Lond) 130:2061–2071. https://doi.org/10.1042/CS20160074
40. Xanthakis V, Enserro DM, Larson MG, Wollert KC, Januzzi JL, Levy D, Aragam J, Benjamin EJ, Cheng S, Wang TJ, Mitchell GF, Vasan RS (2016) Prevalence, neurohormonal correlates, and prognosis of heart failure stages in the community. JACC Heart Fail 4:808–815. https://doi.org/10.1016/j.jchf.2016.05.001
41. Yndestad A, Holm AM, Muller F, Simonsen S, Froland SS, Gullestad L, Aukrust P (2003) Enhanced expression of inflammatory cytokines and activation markers in t-cells from patients with chronic heart failure. Cardiovasc Res 60:141–146